EDITORIAL
Published on 20 Sep 2022
Editorial: Insights in Regulatory Science 2021
doi 10.3389/fmed.2022.1033558
- 827 views
- 2 citations
- Frontiers in Medicine
- Regulatory Science
- Research Topics
- Insights in Regulatory Science: 2021
Insights in Regulatory Science: 2021
31k
Total downloads
232k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 21 Jun 2022
A VOSviewer-Based Bibliometric Analysis of Prescription Refills
doi 10.3389/fmed.2022.856420
- 4,258 views
- 20 citations
ORIGINAL RESEARCH
Published on 13 May 2022
METORY: Development of a Demand-Driven Blockchain-Based Dynamic Consent Platform Tailored for Clinical Trials
doi 10.3389/fmed.2022.837197
- 1,838 views
- 13 citations
POLICY AND PRACTICE REVIEWS
Published on 10 May 2022
20 Years of Legislation - How Australia Has Responded to the Challenge of Regulating Genetically Modified Organisms in the Clinic
doi 10.3389/fmed.2022.883434
- 10,467 views
- 4 citations
BRIEF RESEARCH REPORT
Published on 26 Apr 2022
Biomarkers in Medicines Development—From Discovery to Regulatory Qualification and Beyond
doi 10.3389/fmed.2022.878942
- 4,280 views
- 11 citations
POLICY BRIEF
Published on 15 Apr 2022
Regulatory Approval With Real-World Data From Regulatory Science Perspective in Japan
doi 10.3389/fmed.2022.864960
- 7,193 views
- 5 citations
ORIGINAL RESEARCH
Published on 30 Mar 2022
Perceptions of Regulatory Decision-Making for New Drugs From the Viewpoints of the Manufacturers in South Korea
doi 10.3389/fmed.2022.869262
- 1,686 views
ORIGINAL RESEARCH
Published on 09 Mar 2022
Regulatory Information and Guidance on Biosimilars and Their Use Across Europe: A Call for Strengthened One Voice Messaging
doi 10.3389/fmed.2022.820755
- 9,802 views
- 24 citations
POLICY AND PRACTICE REVIEWS
Published on 03 Feb 2022
Conditional Drug Approval as a Path to Market for Oncology Drugs in Canada: Challenges and Recommendations for Assessing Eligibility and Regulatory Responsiveness
doi 10.3389/fmed.2021.818647
- 5,810 views
- 7 citations
PERSPECTIVE
Published on 13 Jan 2022
The Current Status and Future Direction of Clinical Research in Japan From a Regulatory Perspective
doi 10.3389/fmed.2021.816921
- 9,649 views
- 7 citations
PERSPECTIVE
Published on 12 Jan 2022
Multi-Criteria Decision Analysis for Benefit-Risk Analysis by National Regulatory Authorities
doi 10.3389/fmed.2021.820335
- 6,156 views
- 11 citations
PERSPECTIVE
Published on 09 Dec 2021
Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple Stakeholders
doi 10.3389/fmed.2021.790782
- 4,271 views
- 3 citations
Published in
Frontiers in Medicine
- Regulatory Science
Impact
- 232kTopic views
- 199kArticle views
- 31kArticle downloads